摘要在2019新型冠状病毒（2019-nCoV）感染的新型冠状病毒肺炎（新冠肺炎）患者中，相对于有症状感染者来说，无症状感染者携带的2019-nCoV因其隐匿性和被忽视性，更容易被广泛传播蔓延，从而给当前的新冠肺炎防治工作带来严峻挑战。目前针对无症状感染者的治疗方法尚在探索阶段，通过挖掘祖国医学典籍发现，"邪伏膜原"理论以其"伏而不发或表里九传"的独特辨证体系和"先证用药以截断病原、开达膜原以扭转病位、早逐客邪以防传变、瘥后调护以防复发"的标本兼治疗效，可为中医药治疗新冠肺炎无症状感染者提供临床应用参考，并为进一步发挥中医药在抗击传染病战役中的重要作用提供理论资源。

abstractsAmong coronavirus disease 2019 (COVID-19) patients who infected with 2019 novel coronavirus (2019-nCoV), compared with the symptomatic infection patients, 2019-nCoV carried by asymptomatic infection patients are more likely to be widely spread due to secrecy and neglect, thus brings severe challenges to the current prevention and treatment of COVID-19. The therapies of asymptomatic 2019-nCoV infection are still in research. Through excavating the Chinese medical classics, it was found that the theory of "pathogen hiding in the pleurodiaphragmatic interspace", with its unique syndrome differentiation system and curative effect of treating symptoms and causes, can provide clinical reference for the treatment of asymptomatic 2019-nCoV infections and provide theoretical basis traditional Chinese medicine in the battle against infectious diseases.